BioSpace News Archive

FDA

ITF Secures FDA Approval for Liquid Riluzole for ALS Patients

Privately-held ITF Pharma snagged regulatory approval for Tiglutik, a liquid formulation of riluzole for the treatment of amyotrophic lateral sclerosis.

September 7, 2018
·
2 min read
·
Alex Keown
Business

Elevian Launches to Join Numerous Companies Focused on Longevity and Aging

In another example of companies focused on aging-related diseases, Elevian launched with $5.5 million in seed funding. Elevian’s founders came out of Stanford and then Harvard, focused on regenerative effects of “young blood.”

September 7, 2018
·
3 min read
·
Mark Terry
Business

Movers and Shakers for Sept. 10

Let’s take a look at who made a splash in the pharma and biotech world the past week.

September 7, 2018
·
5 min read
·
Alex Keown
Policy

Shegerian & Associates: “Rehab to the Stars” Treatment Center Sued by Former VP Over Fraud Claims

A former vice president for Passages Addiction Treatment Centers, a Los Angeles company whose posh resorts cater to celebrities and other wealthy individuals seeking substance abuse treatment, has sued the company for retaliating against her due to exposing fraud in the company.

September 7, 2018
·
2 min read
Policy

OPKO Comments on SEC Complaint

OPKO Health, Inc. provided the following comment on the lawsuit filed by the U.S. Securities and Exchange Commission earlier today.

September 7, 2018
·
2 min read
FDA

Tezepelumab Granted Breakthrough Therapy Designation By US FDA For The Treatment Of Patients With Severe Asthma Without An Eosinophilic Phenotype

Designation Supported by Phase 2b PATHWAY Data That Demonstrated Tezepelumab Significantly Reduced Asthma Exacerbations Compared to Placebo in Severe Asthma Patients

September 7, 2018
·
12 min read
Creative Biolabs Launched Bispecific T-cell Engager for Cancer Treatment and Immune Regulation

With more than ten years of experience in serving clinical researches and academic researches, Creative Biolabs developed bispecific t cell engager for cancer treatment and immune regulation researches.

September 7, 2018
·
1 min read
Deals

SOTIO and PPF Complete Acquisition of Cytune Pharma

SOTIO announces today the completion of the acquisition of Cytune Pharma by PPF. SOTIO will continue to develop the lead program SO-C101 (RLI-15) within its pipeline and intends to initiate first-in-human clinical trials in early 2019.

September 7, 2018
·
4 min read
Business

MDxHealth (R): MDxHealth Reports Half Year 2018 Results

Good Operational Progress and Healthy Double-Digit Growth of Clinical Testing Volumes

September 7, 2018
·
13 min read
Business

EVOTEC AND CHDI FOUNDATION EXTEND ONGOING COLLABORATION TO FIGHT HUNTINGTON’S DISEASE

Evotec AG today announced that CHDI Foundation, Inc. (“CHDI”) has extended its collaboration with Evotec through to 2023. Over this period, CHDI may fund up to 75 full-time scientists at Evotec.

September 7, 2018
·
5 min read